RxDoctor Payments Data

Stuart Ditchek

General Practice · Brooklyn, NYNPI 1528068103

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $137,257 of the $170,990 with a category attached, or 80.3%. Sanofi accounts for 99.8% of it on its own, with 4 other manufacturers making up the rest. Among general practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$170,990in general payments, 2019–2025

Across 180 payments — averaging $949.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$171K
  • GSK$210
  • Sanofi Pasteur Inc.$75
  • Pfizer$22
  • Alk-abello, Inc$17

What the payments were for

  • Speaking & faculty fees$137,25780%
  • Travel & lodging$29,76717%
  • Food & beverage$3,9652%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi162$170,666
GSK12$210
Sanofi Pasteur Inc.4$75
Pfizer1$22
Alk-abello, Inc1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$170,990 in reported general payments places this provider in the 95th percentile of 5,764 general practice providers in New York.

See all general practice providers in New York →

Other general practice in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →